Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-hu mice

Sara Deola, Samantha Scaramuzza, Roberto Sciarretta Birolo, Nicole Carballido-Perrig, Francesca Ficara, Cristina Mocchetti, Jonathan Dando, José M. Carballido, Claudio Bordignon, Maria Grazia Roncarolo, Marco Bregni, Alessandro Aiuti

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We developed a clinically applicable gene transfer procedure into mobilized peripheral blood (MPB) CD34+ hematopoietic progenitor cells, based on single viral exposure and selection of engineered cells. CD34+ cells were transduced with a retroviral vector carrying the truncated form of the nerve growth factor receptor (ΔNGFR) marker gene, and immunoselected for ΔNGFR expression. Optimal time and procedure for viral exposure, length of culture, and transgene expression of MPB CD34 + cells were determined using in vitro assays. The multipotent capacity of MPB CD34+-transduced cells was demonstrated in the SCID-hu bone/liver/thymus mouse model. Transduced ΔNGFR+ cells retained 50% of long-term culture-colony forming cells (LTC-CFC) compared to unmanipulated CD34+ cells. In SCID-hu mice, 52% of CD45+ cells, 27% of CD34+ cells, 49% of B cells, and more than 50% of T cells were derived from transplanted CD34+/ΔNGFR+ cells. Furthermore, transplantation of purified transduced cells greatly reduced the competition with untransduced progenitors occurring in unselected grafts. These data demonstrate that MPB CD34+ cells, transduced with a single viral exposure and selected by transgene expression, retain multilineage reconstitution capacity and remarkable transgene expression.

Original languageEnglish
Pages (from-to)305-311
Number of pages7
JournalHuman Gene Therapy
Volume15
Issue number3
DOIs
Publication statusPublished - 1 Mar 2004
Externally publishedYes

Fingerprint

Lymphopoiesis
SCID Mice
Blood Cells
Nerve Growth Factor Receptor
Transgenes
Hematopoietic Stem Cells
Thymus Gland
Genes
B-Lymphocytes
Transplantation

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-hu mice. / Deola, Sara; Scaramuzza, Samantha; Birolo, Roberto Sciarretta; Carballido-Perrig, Nicole; Ficara, Francesca; Mocchetti, Cristina; Dando, Jonathan; Carballido, José M.; Bordignon, Claudio; Roncarolo, Maria Grazia; Bregni, Marco; Aiuti, Alessandro.

In: Human Gene Therapy, Vol. 15, No. 3, 01.03.2004, p. 305-311.

Research output: Contribution to journalArticle

Deola, S, Scaramuzza, S, Birolo, RS, Carballido-Perrig, N, Ficara, F, Mocchetti, C, Dando, J, Carballido, JM, Bordignon, C, Roncarolo, MG, Bregni, M & Aiuti, A 2004, 'Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-hu mice', Human Gene Therapy, vol. 15, no. 3, pp. 305-311. https://doi.org/10.1089/104303404322886156
Deola, Sara ; Scaramuzza, Samantha ; Birolo, Roberto Sciarretta ; Carballido-Perrig, Nicole ; Ficara, Francesca ; Mocchetti, Cristina ; Dando, Jonathan ; Carballido, José M. ; Bordignon, Claudio ; Roncarolo, Maria Grazia ; Bregni, Marco ; Aiuti, Alessandro. / Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-hu mice. In: Human Gene Therapy. 2004 ; Vol. 15, No. 3. pp. 305-311.
@article{2a21516df8b945f8960d43a43a36355e,
title = "Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-hu mice",
abstract = "We developed a clinically applicable gene transfer procedure into mobilized peripheral blood (MPB) CD34+ hematopoietic progenitor cells, based on single viral exposure and selection of engineered cells. CD34+ cells were transduced with a retroviral vector carrying the truncated form of the nerve growth factor receptor (ΔNGFR) marker gene, and immunoselected for ΔNGFR expression. Optimal time and procedure for viral exposure, length of culture, and transgene expression of MPB CD34 + cells were determined using in vitro assays. The multipotent capacity of MPB CD34+-transduced cells was demonstrated in the SCID-hu bone/liver/thymus mouse model. Transduced ΔNGFR+ cells retained 50{\%} of long-term culture-colony forming cells (LTC-CFC) compared to unmanipulated CD34+ cells. In SCID-hu mice, 52{\%} of CD45+ cells, 27{\%} of CD34+ cells, 49{\%} of B cells, and more than 50{\%} of T cells were derived from transplanted CD34+/ΔNGFR+ cells. Furthermore, transplantation of purified transduced cells greatly reduced the competition with untransduced progenitors occurring in unselected grafts. These data demonstrate that MPB CD34+ cells, transduced with a single viral exposure and selected by transgene expression, retain multilineage reconstitution capacity and remarkable transgene expression.",
author = "Sara Deola and Samantha Scaramuzza and Birolo, {Roberto Sciarretta} and Nicole Carballido-Perrig and Francesca Ficara and Cristina Mocchetti and Jonathan Dando and Carballido, {Jos{\'e} M.} and Claudio Bordignon and Roncarolo, {Maria Grazia} and Marco Bregni and Alessandro Aiuti",
year = "2004",
month = "3",
day = "1",
doi = "10.1089/104303404322886156",
language = "English",
volume = "15",
pages = "305--311",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-hu mice

AU - Deola, Sara

AU - Scaramuzza, Samantha

AU - Birolo, Roberto Sciarretta

AU - Carballido-Perrig, Nicole

AU - Ficara, Francesca

AU - Mocchetti, Cristina

AU - Dando, Jonathan

AU - Carballido, José M.

AU - Bordignon, Claudio

AU - Roncarolo, Maria Grazia

AU - Bregni, Marco

AU - Aiuti, Alessandro

PY - 2004/3/1

Y1 - 2004/3/1

N2 - We developed a clinically applicable gene transfer procedure into mobilized peripheral blood (MPB) CD34+ hematopoietic progenitor cells, based on single viral exposure and selection of engineered cells. CD34+ cells were transduced with a retroviral vector carrying the truncated form of the nerve growth factor receptor (ΔNGFR) marker gene, and immunoselected for ΔNGFR expression. Optimal time and procedure for viral exposure, length of culture, and transgene expression of MPB CD34 + cells were determined using in vitro assays. The multipotent capacity of MPB CD34+-transduced cells was demonstrated in the SCID-hu bone/liver/thymus mouse model. Transduced ΔNGFR+ cells retained 50% of long-term culture-colony forming cells (LTC-CFC) compared to unmanipulated CD34+ cells. In SCID-hu mice, 52% of CD45+ cells, 27% of CD34+ cells, 49% of B cells, and more than 50% of T cells were derived from transplanted CD34+/ΔNGFR+ cells. Furthermore, transplantation of purified transduced cells greatly reduced the competition with untransduced progenitors occurring in unselected grafts. These data demonstrate that MPB CD34+ cells, transduced with a single viral exposure and selected by transgene expression, retain multilineage reconstitution capacity and remarkable transgene expression.

AB - We developed a clinically applicable gene transfer procedure into mobilized peripheral blood (MPB) CD34+ hematopoietic progenitor cells, based on single viral exposure and selection of engineered cells. CD34+ cells were transduced with a retroviral vector carrying the truncated form of the nerve growth factor receptor (ΔNGFR) marker gene, and immunoselected for ΔNGFR expression. Optimal time and procedure for viral exposure, length of culture, and transgene expression of MPB CD34 + cells were determined using in vitro assays. The multipotent capacity of MPB CD34+-transduced cells was demonstrated in the SCID-hu bone/liver/thymus mouse model. Transduced ΔNGFR+ cells retained 50% of long-term culture-colony forming cells (LTC-CFC) compared to unmanipulated CD34+ cells. In SCID-hu mice, 52% of CD45+ cells, 27% of CD34+ cells, 49% of B cells, and more than 50% of T cells were derived from transplanted CD34+/ΔNGFR+ cells. Furthermore, transplantation of purified transduced cells greatly reduced the competition with untransduced progenitors occurring in unselected grafts. These data demonstrate that MPB CD34+ cells, transduced with a single viral exposure and selected by transgene expression, retain multilineage reconstitution capacity and remarkable transgene expression.

UR - http://www.scopus.com/inward/record.url?scp=12144291490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144291490&partnerID=8YFLogxK

U2 - 10.1089/104303404322886156

DO - 10.1089/104303404322886156

M3 - Article

VL - 15

SP - 305

EP - 311

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 3

ER -